Nuo Therapeutics Inc AURX
$1.03 $1.03
Last Updated: Aug 21, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
Nuo Therapeutics Inc. Stock Analysis AURX
United States N/A Nano Cap Nuo Therapeutics, Inc. engages in the development and sale of biomedical products for chronic wound care. The company is headquartered in Houston, Texas. The company went IPO on 2017-01-19. The firm is focused on developing and marketing products for chronic wound care primarily within the United States. The company has commercialized cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The firm's product, Aurix, is a biodynamic hematogel that uses a patient’s own platelets and plasma as a catalyst for healing. Its commercial offering consists of a point of care technology for the separation of autologous blood to produce a platelet-based therapy for use in the chronic wound care market. The Aurix System produces a platelet-rich plasma (PRP) gel at the point of care using the patient’s own platelets and plasma sourced from a small draw of peripheral blood. The Aurix PRP comprises a natural, endogenous complement of protein and non-protein signal molecules that are believed to contribute to effective healing.
Nuo Therapeutics Inc (AURX) Chart
Financial Metrics & Statements of Nuo Therapeutics Inc (AURX)
FAQ's for Nuo Therapeutics Inc (AURX)
- As of August 2026, Nuo Therapeutics Inc AURX is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Nuo Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Nuo Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Nuo Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Nuo Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Nuo Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Nuo Therapeutics Inc (AURX)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
